Source:http://linkedlifedata.com/resource/pubmed/id/21459819
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
2011-4-4
|
pubmed:abstractText |
Naturally acquired immunity to Plasmodium falciparum's asexual blood stage reduces parasite multiplication at microscopically detectable densities. The effect of natural immunity on initial prepatent parasite multiplication during the period following a new infection has been uncertain, contributing to doubt regarding the utility of experimental challenge models for blood-stage vaccine trials. Here we present data revealing that parasite multiplication rates during the initial prepatent period in semi-immune Gambian adults are substantially lower than in malaria-naive participants. This supports the view that a blood-stage vaccine capable of emulating the disease-reducing effect of natural immunity could achieve a detectable effect during the prepatent period.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1537-6613
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
1
|
pubmed:volume |
203
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1337-40
|
pubmed:meshHeading |
pubmed-meshheading:21459819-Adaptive Immunity,
pubmed-meshheading:21459819-Adult,
pubmed-meshheading:21459819-Gambia,
pubmed-meshheading:21459819-Humans,
pubmed-meshheading:21459819-Malaria, Falciparum,
pubmed-meshheading:21459819-Microscopy,
pubmed-meshheading:21459819-Parasitology,
pubmed-meshheading:21459819-Plasmodium falciparum
|
pubmed:year |
2011
|
pubmed:articleTitle |
Substantially reduced pre-patent parasite multiplication rates are associated with naturally acquired immunity to Plasmodium falciparum.
|
pubmed:affiliation |
Jenner Institute, Nuffield Department of Medicine, University of Oxford, UK. sandy.douglas@ndm.ox.ac.uk
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|